Phase I trial of remimazolam to assess the abuse potential

Trial Profile

Phase I trial of remimazolam to assess the abuse potential

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Remimazolam (Primary)
  • Indications Sedation
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Aug 2017 According to a PAION media release, part 1 with twelve subject successfully completed.
    • 09 Aug 2017 According to a PAION media release, before conducting this study, interations with FDA are planned in fourth quarter 2017.
    • 23 Mar 2017 Company is planning multiple Phase I studies to assess the abuse potential of remimazolam, for now created only one profile. But may need to create more profiles based on more specific info. about two aspcts of the trial/s.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top